Location pin
LAS VEGAS | 1 & 2 SEPT 2021 SOUTH HALL LVCC USA
NEW YORK | 30 SEPT & 1 OCT 2021 JAVITS CENTER
EUROPE | 13 & 14 OCT 2021 MESSE FRANKFURT
UNITED KINGDOM | 2 & 3 MARCH 2022 ExCeL LONDON
The White Label World Expo USA logo
Return to Speaker page
Cindy Abrams, RN & Dr. John Streicher, Ph.D.: Speaking at the White Label World Expo USA

Cindy Abrams, RN & Dr. John Streicher, Ph.D.

Medical Advisor / Chief Science Officer - Botanical Results – Hemp Essence / Divine Elements


Improving Post-Aesthetic Treatment Results and Neuropathic Pain with CBD & Terpene Infused Creams

We will discuss CBD & active terpenes’ impact on neuropathic pain and healing following aesthetics treatment discomfort. In addition, CBD cream with active terpenes was also shown in mice studies to reduce neuropathic pain, which gives it potential to treat other nerve-related disease processes.

About Cindy Abrams, RN & Dr. John Streicher, Ph.D.

Dr. John Streicher, Ph.D.: Dr. John Streicher earned his PhD from UCLA in 2009, in the lab of Dr. Yibin Wang, where he studied the signal transduction cascades linking heart stress to heart failure. He then went on to a postdoctoral fellowship with Dr. Laura Bohn at Scripps-Florida, where he studied biased signalling at the opioid receptors. In 2012, he joined the faculty at the University of New England, where he combined the threads of his training into a research program focused on the signal transduction cascades of the opioid, cannabinoid, and other brain-relevant receptors, mostly in the context of pain. He joined the faculty of the University of Arizona in 2015, where he continues his work today. Recently, his research program has focused on the effects of terpene compounds found in Cannabis sativa. In a recent paper published in Scientific Reports, his lab found that alpha-humulene, beta-pinene, linalool, and geraniol produced cannabinoid-like effects in mice. This work recently secured funding from the National Institutes of Health to investigate terpenes as potential non-opioid, non-cannabinoid treatments for chronic pain with reduced side effects.

Cindy Abrams, RN: Cindy Abrams is a registered nurse with over 49 years’ experience, with progressive leadership positions in operations, business development, clinical research, as well as clinical nursing. While an undergraduate working as a Research Assistant at the University of Arizona, she designed and implemented the Pilot study for Colon Cancer Prevention which launched colon cancer research that is still in progress today. In collaboration with the College of Nursing, she assisted with the development of predictive tools in relationship to compliance with dietary and other healthy habit changes. The Health Locus of Control tool developed for that study in 1994 is still utilized in dietary compliance studies today. She has also served as a clinical leader in development of a successful hospice, as well as a physician’s group.